BPC-157 has shown localized effects on tendon, ligament and gut tissue and strong pro-angiogenic activity in preclinical models[1]
A rare but significant concern is medullary thyroid carcinoma, as well as multiple endocrine neoplasia syndrome type 2 (MEN 2), and any family history of these conditions should be discussed prior to treatment with Zepbound
One critical detail that most online resources omit: BPC-157 and TB-500 must be administered from separate vials
That said, it is not FDA-approved, so it should only be considered under licensed medical supervision
Please remember that scrubbing brushes, like Clarisonic, are exfoliating, and that is too much to do for at least 3-4 days after this laser, if not a week
[2] Use of estradiol cypionate injection is contraindicated in individuals with undiagnosed abnormal vaginal bleeding, known or suspected breast cancer or other estrogen-dependent neoplasia, active or prior venous thromboembolism, recent arterial thrombo-occlusive disease such as stroke or myocardial infarction, severe hepatic impairment, a history of hypersensitivity to estradiol or any excipients, and in those who are or may become pregnant
